Evidence map›Paper›PMID 39130089›Full record

ArticleRespirology case reports2024

A potential prospect: The novel treatment of intrapleural saline irrigation with intrapleural tyloxapol in treating thoracic empyema.

Mas Fazlin Mohamad Jailaini, Noor Amirah Saini, Mohd Jazman Che Rahim, Mohamed Faisal Abdul Hamid

Registry-linked trialAbstract readCase Reports
In one paragraph

Article in Respirology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07432373 (Comparative Analysis of Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07432373 recruitingnot on this mapstarted 2026, after this paper: background citation

Comparative Analysis of Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection (ALTON-PI)

TypeobservationalSponsorNational University of MalaysiaRan2026 to 2028Enrolled80ConditionsPleural InfectionArmsIntrapleural t-PA/Dnase arm, t-PA (Alteplase) 5-10mg and Tyloxapol 200mg
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mas Fazlin Mohamad JailainiRespiratory Unit, Faculty of Medicine Universiti Kebangsaan Malaysia (UKM) Kuala Lumpur Malaysia.ORCID https://orcid.org/0000-0003-2312-5108
Noor Amirah SainiRespiratory Unit, Faculty of Medicine Universiti Kebangsaan Malaysia (UKM) Kuala Lumpur Malaysia.
Mohd Jazman Che RahimRespiratory Unit, Faculty of Medicine Universiti Sains Malaysia (USM) Kota Bharu Malaysia.ORCID https://orcid.org/0000-0003-1721-6329
Mohamed Faisal Abdul HamidRespiratory Unit, Faculty of Medicine Universiti Kebangsaan Malaysia (UKM) Kuala Lumpur Malaysia.ORCID https://orcid.org/0000-0002-7526-361X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment for empyema thoracis has been evolving over the years, including the usage of intrapleural fibrinolytic therapy (IPFT), for example, alteplase with intrapleural deoxyribonuclease (DNase) to enhance the drainage of pleural effusion. Here, we report two cases of thoracic empyema that were successfully treated with intrapleural saline irrigation and intrapleural tyloxapol apart from parenteral antibiotics as the pillar of the treatment. Both patients averted surgical procedure (decortication) and were discharged well. Upon follow-up, both cases showed clinical cure, biochemical recovery, and radiological improvement, indicating a good treatment outcome. This is the first reported cases on combination of saline irrigation with tyloxapol as alternative treatment for pleural infection.

Indexed as

empyema thoracisintrapleural saline irrigationtacholiquintyloxapol

Identifiers

PMID39130089
PMCPMC11316260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.